Health & Pharma
CVS Is Unwinding the Deal That Built It
CVS will separate its roughly 9,000 drugstores from Aetna and Caremark by mid-2028, unwinding the vertical integration the 2018 Aetna merger created. Shares fell 12% anyway, despite a quarterly beat and raised guidance.
- J&J's Rybrevant Wins the First New Second-Line Head and Neck Cancer Drug in a Decade
- FDA Approves the First DNA-Based Immunotherapy, on a 32-Patient Trial
- A Catholic Nonprofit Is Taking Surgery Partners Private
- Hepatitis B's First Functional Cure Reaches the US Market
- AstraZeneca's Ultomiris Cuts IgAN Proteinuria 43%, but the Kidney Proof Is Still Pending
- GSK's New Drug Could Spare Rectal Cancer Patients Surgery
- Spire’s £1.03 Billion Takeover Shifts the Hospital Cost Test to Private Capital
- SEC-FDA Data Pact Tightens the Disclosure Test for Life-Sciences Companies











































